These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9227335)

  • 21. [Morphological diagnosis and classification of lung tumors].
    Kraft R
    Ther Umsch; 1994 Apr; 51(4):231-7. PubMed ID: 8191386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
    Ionescu DN; Treaba D; Gilks CB; Leung S; Renouf D; Laskin J; Wood-Baker R; Gown AM
    Am J Surg Pathol; 2007 Jan; 31(1):26-32. PubMed ID: 17197916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine tumors of the lung.
    Marchevsky AM
    Pathology (Phila); 1996; 4(1):103-23. PubMed ID: 8953616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular expression of interleukin 2 (IL-2) and its receptor (IL-2R, CD25) in lung tumours.
    Kasprzak A; Olejniczak K; Przybyszewska W; Zabel M
    Folia Morphol (Warsz); 2007 Aug; 66(3):159-66. PubMed ID: 17985312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine neoplasms of the lung: a prognostic spectrum.
    Asamura H; Kameya T; Matsuno Y; Noguchi M; Tada H; Ishikawa Y; Yokose T; Jiang SX; Inoue T; Nakagawa K; Tajima K; Nagai K
    J Clin Oncol; 2006 Jan; 24(1):70-6. PubMed ID: 16382115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung tumours with neuroendocrine differentiation.
    Travis WD
    Eur J Cancer; 2009 Sep; 45 Suppl 1():251-66. PubMed ID: 19775623
    [No Abstract]   [Full Text] [Related]  

  • 27. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
    Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
    Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transitions between lung cancer phenotypes--implications for tumor progression.
    Mabry M; Nelkin BD; Falco JP; Barr LF; Baylin SB
    Cancer Cells; 1991 Feb; 3(2):53-8. PubMed ID: 1851429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies in lung cancer pathology.
    Broers JL; Klein Rot M; de Leij L; Wagenaar SS; Carney DN; Vooijs GP; Ramaekers FC
    Eur J Respir Dis Suppl; 1987; 149():11-8. PubMed ID: 2438150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy.
    Howe MC; Chapman A; Kerr K; Dougal M; Anderson H; Hasleton PS
    Histopathology; 2005 Feb; 46(2):195-201. PubMed ID: 15693892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers.
    Senden NH; Timmer ED; de Bruïne A; Wagenaar SS; Van de Velde HJ; Roebroek AJ; Van de Ven WJ; Broers JL; Ramaekers FC
    J Pathol; 1997 May; 182(1):13-21. PubMed ID: 9227337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paucity of beta 2-microglobulin expression on small cell lung cancer, bronchial carcinoids and certain other neuroendocrine tumors.
    Funa K; Gazdar AF; Minna JD; Linnoila RI
    Lab Invest; 1986 Aug; 55(2):186-93. PubMed ID: 3525983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.
    Travis WD
    Thorac Surg Clin; 2014 Aug; 24(3):257-66. PubMed ID: 25065926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutive achaete-scute homologue-1 promotes airway dysplasia and lung neuroendocrine tumors in transgenic mice.
    Linnoila RI; Zhao B; DeMayo JL; Nelkin BD; Baylin SB; DeMayo FJ; Ball DW
    Cancer Res; 2000 Aug; 60(15):4005-9. PubMed ID: 10945598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma.
    Peng WX; Sano T; Oyama T; Kawashima O; Nakajima T
    Lung Cancer; 2005 Feb; 47(2):225-33. PubMed ID: 15639721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neuroendocrine tumors of the lung].
    Oliaro A; Donati G; Filosso PL; Ruffini E
    Minerva Chir; 2000; 55(1-2):7-16. PubMed ID: 10832278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New data in the classification of pulmonary neuroendocrine proliferation].
    Lantuejoul S; Brambilla E
    Ann Pathol; 2000; 20 Suppl():S131-4. PubMed ID: 11261291
    [No Abstract]   [Full Text] [Related]  

  • 38. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
    Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
    Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary carcinoid and related tumours.
    Hasleton PS; Bostanci G
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():28-42. PubMed ID: 9337521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers.
    Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M
    Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.